210 related articles for article (PubMed ID: 10699057)
1. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG).
Eccles DM; Evans DG; Mackay J
J Med Genet; 2000 Mar; 37(3):203-9. PubMed ID: 10699057
[TBL] [Abstract][Full Text] [Related]
2. Contribution of extended family history in assessment of risk for breast and colon cancer.
Solomon BL; Whitman T; Wood ME
BMC Fam Pract; 2016 Sep; 17(1):126. PubMed ID: 27580697
[TBL] [Abstract][Full Text] [Related]
3. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
[TBL] [Abstract][Full Text] [Related]
4. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
[TBL] [Abstract][Full Text] [Related]
6. Why do women not return family history forms when referred to breast cancer genetics services? A mixed-method study.
Hanning KA; Steel M; Goudie D; McLeish L; Dunlop J; Myring J; Sullivan F; Berg J; Humphris G; Ozakinci G
Health Expect; 2015 Oct; 18(5):1735-43. PubMed ID: 24386893
[TBL] [Abstract][Full Text] [Related]
7. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
[TBL] [Abstract][Full Text] [Related]
8. A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites.
Mouchawar J; Byers T; Cutter G; Dignan M; Michael S
Cancer Detect Prev; 1999; 23(1):22-30. PubMed ID: 9892987
[TBL] [Abstract][Full Text] [Related]
9. Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
Aitken L; Warwick L; Davis A
Intern Med J; 2017 Mar; 47(3):311-317. PubMed ID: 28019080
[TBL] [Abstract][Full Text] [Related]
10. [Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screening].
Lassetn C; Bonadona V
Bull Cancer; 2001 Jul; 88(7):677-86. PubMed ID: 11495821
[TBL] [Abstract][Full Text] [Related]
11. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
[TBL] [Abstract][Full Text] [Related]
12. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
13. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
Khabele D; Runowicz CD
Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
[TBL] [Abstract][Full Text] [Related]
14. [Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].
Bürki N
Ther Umsch; 2010 Jul; 67(7):359-66. PubMed ID: 20577964
[TBL] [Abstract][Full Text] [Related]
15. Clinical assessment of breast cancer risk based on family history.
Ready K; Arun B
J Natl Compr Canc Netw; 2010 Oct; 8(10):1148-55. PubMed ID: 20971839
[TBL] [Abstract][Full Text] [Related]
16. Cancer Recognition and Screening for Common Breast Disorders and Malignancy.
Bohon C
Obstet Gynecol Clin North Am; 2017 Jun; 44(2):257-270. PubMed ID: 28499535
[TBL] [Abstract][Full Text] [Related]
17. Implementing a Population-Based Breast Cancer Risk Assessment Program.
Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A
Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694
[TBL] [Abstract][Full Text] [Related]
18. Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment.
MacDonald DJ; Choi J; Ferrell B; Sand S; McCaffrey S; Blazer KR; Grant M; Weitzel JN
J Med Genet; 2002 Jul; 39(7):526-30. PubMed ID: 12114489
[No Abstract] [Full Text] [Related]
19. Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population.
Dominguez FJ; Jones JL; Zabicki K; Smith BL; Gadd MA; Specht M; Kopans DB; Moore RH; Michaelson JS; Hughes KS
Cancer; 2005 Nov; 104(9):1849-53. PubMed ID: 16136597
[TBL] [Abstract][Full Text] [Related]
20. Genetic risk assessment for breast and ovarian cancer.
O'Rourke Tiffen J; Pfeifer K; Fishman DA
Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
